Showing:
◈ medicine×
We need to forge alliances to continue our global health leadership, writes the director of the Independent Commission on UK-EU Relations.
‘No-deal’ Brexit: what the Government’s plans could mean for cancer treatment, care and research
30/08/2018
So how would a no-deal Brexit affect cancer patients and research?
DISRUPTION to medical supplies and potential coronavirus vaccines as a result of Brexit cannot be ruled out, Scotland’s Deputy First Minister has said.
Collapsed trade talks, new border checks, 14-hour queues at the border and medicine shortages... it's just another day in Brexit land.
Supplies of half of all veterinary drugs at risk due to restrictions on importing medicines from Britain.
£2.1bn extra for no-deal planning
01/08/2019
The government has announced an extra £2.1bn of funding to prepare for a no-deal Brexit - doubling the amount of money it has set aside this year.
The European Medicines Agency or EMA ensures that the medicines in the European Union are effective and safe. Find out what EMA is in a nutshell and how it protects patients.
Why would anyone trust Brexit Britain again?
24/07/2021
Just seven months after singing its praises, British Prime Minister Boris Johnson is attempting to rewrite the Brexit deal he signed with the European Union.
Post-Brexit, the cost of medicines they rely on could skyrocket.
Global issues are factor but experts say there are problems peculiar to Britain such as rising costs post-Brexit.
The Yellowhammer report suggests medical supplies could be disrupted by a no-deal but a fragile system means it’s more complicated than that.
A comprehensive guide to the massive impact likely if the UK crashes out of the EU.
What has Brexit meant for the NHS?
10/02/2023
Mark Dayan assesses the impact of Brexit on the health service, looking at the effect on funding, the workforce and medicine supplies.
What happens if we have no deal?
15/10/2020
Mr Johnson told his cabinet this week that leaving the EU without a deal should hold “no fear” for Britain, but was he right?
A no-deal Brexit will be grim for patients. Yet gagging orders are being used to keep the truth from coming out.
With fears over manufacturing costs and future investment, here’s what firms are doing.
We’re running out of time. If post-Brexit negotiations don’t prioritise health, we won’t get through a second wave
30/06/2020
Everyone is fishing in the same pond. Stocks built up in readiness for Brexit are having to be replenished. If another pandemic strikes, we’ll hardly be in the best position to get through it.
Ministers still have a “significant amount” of work to do to ensure the continued supply of vital medicines to the NHS in the event of a no-deal Brexit, the Whitehall spending watchdog has warned.
Warning that Brexit red tape could led to vital drugs for epilepsy and cancer being withdrawn in Northern Ireland
20/04/2021
BREXIT red tape is leading to the withdrawal of vital drugs from Northern Ireland due to the high costs for manufacturers, an industry chief has warned.
EU moves to guarantee supply of medicines to Northern Ireland have so far worked but there are looming issues, peers have heard.
A Wales-based drugs manufacturer has been forced to move to Ireland because of Brexit, it has been claimed.
Shortages could occur within weeks of no-deal Brexit, pharmaceutical industry says. / Crashing out of the EU on 31 October would have serious implications for hospitals, patients and pharmacies, with shortages of some medicines within weeks, MPs have been told by the pharmaceutical industry.